Micronuclei assessment of the radioprotective effects of melatonin and Vitamin C in human lymphocytes by Rostami, A. et al.
 CELL JOURNAL(Yakhteh), Vol 18, No 1, Apr-Jun (Spring) 2016 46
Original Article
Micronuclei Assessment of The Radioprotective Effects of 
Melatonin and Vitamin C in Human Lymphocytes
 
Aram Rostami, M.Sc.1*, Seyed Akbar Moosavi, Ph.D.2, Hassan Dianat Moghadam, B.Sc.3, 
Eftekhar Rajab Bolookat, M.Sc.4
1. Department of  Medical Physics, School of  Medicine-International Campus, Iran University of Medical Sciences, 
Tehran, Iran
2. Department of Lab Sciences, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
3. Department of Medical Biotechnology, School of Advanced Technology, Tehran University of Medical Sciences, 
Tehran, Iran
4. Department of Radiotherapy, Hospital of Shohada Tajrish, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*Corresponding Address: P.O.Box: 14512-6183, Department of  Medical Physics, School of  Medicine-International
 Campus, Iran University of Medical Sciences, Tehran, Iran
Email: rostamy_1969@yahoo.com
 
Received: 17/Mar/2015, Accepted: 24/May/2015
Abstract
Objective: Critical macromolecules such as DNA maybe damaged by free radicals that 
are generated from the interaction of ionizing radiation with biological systems. Melatonin 
and vitamin C have been shown to be direct free radical scavengers. The aim of this study 
was to investigate the in vivo/in vitro radioprotective effects of melatonin and vitamin C 
separately and combined against genotoxicity induced by 6 MV x-ray irradiation in human 
cultured blood lymphocytes.
Materials and Methods: In this experimental study, fifteen volunteers were divided into 
three groups of melatonin, vitamin C and melatonin plus vitamin C treatment. Peripheral 
blood samples were collected from each group before, and 1, 2 and 3 hours after mela-
tonin and vitamin C administration (separately and combined). The blood samples were 
then irradiated with 200 cGy of 6 MV x-ray. In order to characterize chromosomal aber-
rations, the lymphocyte samples were cultured with mitogenic stimulus on cytokinesis-
blocked binucleated cells.       
Results: The samples collected 1hour after melatonin and vitamin C (separately and 
combined) ingestion exhibited a significant decrease in the incidence of micronuclei com-
pared with their control group (P<0.05). The maximum synergic protection and reduction 
in frequency of micronuclei (57%) was observed 1 hour after vitamin C and melatonin 
administration combined.                 
Conclusion: We conclude that simultaneous administration of melatonin and vitamin C 
as radioprotector substances before irradiation may reduce genotoxicity caused by x-ray 
irradiation.      
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Introduction
Irradiation due to radiotherapy or natural and 
industrial sources can damage the human tissues 
considerably (1). It has been recognized that the 
most critical target for transferring ionizing radia-
tion in living tissue is the DNA (genetic material) 
that exists in the nucleus and mitochondria of most 
cells (2). Ionizing radiation generates reactive ox-
ygen species (ROS) in irradiated cells. The free 
radicals such as hydroxyl (˚OH) and active hydror-
gen (˚H) can induce damage to the DNA in cells. 
Mutations and malignant lesions may be caused 
by these cellular DNA damages (3). Radiation-
induced cellular damages are attributed mainly to 
the harmful effects of the free radicals. Molecules 
with the ability to sweep free radicals are thus use-
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ful, particularly as radioprotectors (4). Melatonin 
(N-acetyl-5methoxytryptamine) and Vitamin C 
are two well-known and established radioprotec-
tors (5). Melatonin is an endogenous compound 
that is synthesized by the pineal gland in the hu-
man brain (6-8). It was shown that melatonin is 
a direct free radical scavenger (9). Melatonin is 
also an indirect antioxidant agent by stimulating 
antioxidant enzyme activity and inhibiting pro-
oxidative enzyme activity (10-12). Many studies 
have indicated that both acute and chronic toxicity 
of melatonin is negligible. For instance, no nega-
tive side effects were observed in human volun-
teers orally ingesting melatonin at a dose of 1-300 
mg or 1g for 30 days (13). Antioxidant vitamins 
have been also studied extensively for their capa-
bility of protecting human cells against induced 
damages by irradiation (14). It is well known that 
antioxidant vitamins such as vitamin C can pro-
tect cellular DNA and membranes from radiation-
induced damages. The radioprotective effect of 
vitamin C is through scavenging molecular oxy-
gen, hydroxyl radicals and atomic oxygen radicals 
(5). Chromosomal damages were assessed in this 
study by micronuclei analysis that is a powerful 
method in human biomonitoring of in vivo geno-
toxin exposure. Micronuclei may originate from 
either acentric chromosomal fragments or whole 
chromosome delay in the anaphase stage. This as-
say has been used widely to investigate the effects 
of potential radioprotector agents (15).
Although many in vitro studies have shown that 
treatment of human peripheral blood lymphocytes 
with melatonin and vitamin C reduces the micro-
nuclei induced by gamma irradiation (4, 5), the ef-
ficacy of this treatment is yet to be evaluated in 
vivo by oral ingestion. In this study, we therefore 
evaluated the efficacy of the radioprotective ef-
fects of melatonin and vitamin C separately and 
combined against 6 MV x-ray radiation on human 
blood lymphocytes.
Materials and Methods
This experimental study was approved by the 
Ethics Committee of  Iran University of Medical 
Sciences. Informed consent was obtained from 
fifteen healthy and non-smoking male volunteers 
with an average weight of 65 kg and mean age of 
26 ± 3 years. The selected individuals had no his-
tory of pharmacotherapy for at least two months 
before sampling and did not suffer from any seri-
ous acute or chronic illness. The volunteers were 
divided into three groups, namely A, B and C. 
After overnight fasting, five volunteers (group A) 
were given a single oral dose of two gelatin cap-
sules each containing 300 mg melatonin (Natrol® 
company), five volunteers (group B) were given 
two capsules each containing 300 mg of vitamin 
C (Baker England) and five volunteers (group C) 
were given a combination of both melatonin (one 
capsule) and vitamin C (one capsule). Blood sam-
ples were collected in heparinized tubes before (0 
hour), and 1, 2, and 3 hours after melatonin (group 
A), vitamin C (group B) and melatonin plus vita-
min C (group C) ingestion.
For each volunteer at each sampling time, 1 ml 
of heparinized blood was divided into two halves 
and poured into two 25 ml culture flasks. One 
culture flask was kept as a non-irradiated control 
sample and another one was irradiated with a 6 
MV x-ray accelerator unit (Oncor, Siemens) at 
37˚C. The accelerator was calibrated for irradir-
ating human whole blood samples. To assess the 
calibration of the accelerator, a 200 cGy test run 
was performed on a tube filled with water and ac-
curacy of dose distribution was estimated at about 
4%. To measure radiation dose, thermolumines-
cent dosimeter (TLD) was used and after expo-
sure, the TLDs were read by HARSHAW TLD 
3500 Manual Reader. Obtained results of TLDs 
indicated that radiation dose has an accuracy of 
4% were 200.04, 196 and 200.02 cGy for the top, 
bottom and the middle of the test tube respective-
ly, for 200 cGy irradiation (16). After, irradiation 
was performed with a dose of 200 cGy at 100 cm 
SSD, 10 cm2 field size and 0.731 cGy per monitor 
unit (MU) output factor.
Subsequently, each sample (non-irradiated and 
irradiated) was added to 4.5 ml of RPMI 1640 cul-
ture medium (Sigma, USA) containing 20% fetal 
calf serum, 100 µl/ml phytohaemagglutinin (Sig-
ma, USA), 100 μl/ml penicillin, 250 µg/ml strep-
tomycin and 2 mM glutamine (Sigma, USA). All 
cultures were incubated at 37 ± 1˚C in a humidie-
fied atmosphere of 5% CO2 and 95% O2. After 48 
hours of culture, Cytochalasin B (Sigma Aldrich, 
final concentration: 30 µl/ml) was added to the 
samples. After 72 hours of incubation, cells were 
collected by centrifuging at 800 rpm for 5 minutes. 
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The collected cells were suspended again in 0.075 
M cold potassium chloride (KCl) and centrifuged 
at 800 rpm for 6 minutes and instantly fixed in a 
fixative solution (methanol: acetic acid, 6:1) for 3 
times. To prepare the microscopic slides, the fixed 
cells were dropped onto clean microscopic slides, 
air-dried and stained with Giemsa solution. As-
sessment of slides was carried out at ×1000 mag-
nification to determine the numbers of micronuclei 
in cytokinesis-blocked binucleate cells with the 
cytoplasm remaining intact. To score small nuclei 
as such, the following criteria were considered: di-
ameter ranging from 1/16 to 1/3 of the diameter 
of the main nuclei, being non-refractive, no link 
or overlap with the main nuclei. For every volun-
teer and at each blood sampling time, for irradiated 
and control samples, 1000 cells were evaluated to 
score the frequency of micronuclei.
Statistical analysis 
The student t test was used to compare incidence 
of micronuclei in each time point (1, 2, 3 hours) 
in three groups (A, B and C) with the irradiated 
control point (at 0 hour). The level of statistical 
significance was set to P<0.05.
Results
We observed no side effects after the single oral 
ingestion of melatonin and vitamin C (separately 
and combined). Tables 1, 2 and 3 show a signifi-
cant increase for the incidence of micronuclei in 
irradiated lymphocytes compared with the control 
cells without irradiation. A typical micronucleated 
binucleate cells shown in Figure 1.
The percentage of micronuclei induced by ir-
radiation in group A lymphocytes after 1, 2 and 
3 hours of melatonin ingestion was 5.86 ± 2.32, 
8.67 ± 1.24 and 10.28 ± 0.9, respectively. The 
frequency of micronuclei found in melatonin-
treated cell groups was significantly lower than 
the control group. For the blood samples collect-
ed 1 hour after the oral melatonin ingestion and 
exposed in vitro to 200 cGy of 6 MV radiation, 
a significant decrease in the incidence of micro-
nuclei was observed when compared with corre-
sponding samples collected at 0 hour (P<0.001). 
The incidence of total micronuclei was reduced 
to 55% at 1 hour after oral melatonin ingestion. 
Total micronuclei were typically lower at 1 hour 
compared with those at 2 and 3 hours after oral 
melatonin ingestion (Table 1).
The percentage of the micronuclei induced by ir-
radiation in group B human lymphocytes after 1, 2 
and 3 hours of vitamin C administration was 7.13 
± 1.9, 9.86 ± 1.11 and 10.80 ± 0.6 respectively. 
The frequency of micronuclei found in vitamin C-
treated cell groups was significantly lower than the 
control group. For the blood samples collected 1 
hour after oral vitamin C ingestion and exposed 
in vitro to 200 cGy of 6 MV x-ray radiation, a sig-
nificant decrease in the incidence of micronuclei 
was observed when compared with corresponding 
samples collected at 0 hour (P<0.001). Total mi-
cronuclei were reduced to 65% at 1 hour after oral 
vitamin C administration. The incidence of total 
micronuclei was typically lower at 1 hour com-
pared with those at 2 and 3 hours after oral vitamin 
C ingestion (Table 2).
The percentage of the micronuclei induced by 
irradiation in group C human lymphocytes after 
1, 2 and 3 hours of simultaneous melatonin and 
vitamin C administration was 4.66 ± 2.7, 7.90 ± 
1.9 and 9.10 ± 0.9 respectively. The frequency of 
micronuclei found in melatonin and vitamin C-
treated cell groups was significantly lower than 
the control group. For the blood samples collected 
1hour after oral melatonin plus vitamin C inges-
tion (combined) and exposed in vitro to 200 cGy of 
6 MV x-ray radiation, a significant decrease in the 
incidence of micronuclei was observed when com-
pared with corresponding samples collected at 0 
hour (P<0.001). Total micronuclei were decreased 
to 43% at 1 hour after melatonin+vitamin C inges-
tion (combined). The incidence of total micronu-
clei was typically lower at 1 hour when compared 
with those at 2 and 3 hours after oral melatonin 
plus vitamin C ingestion (combined) as shown in 
Table 3.
The results of this study indicated that the pro-
tection efficacy of melatonin is better than vitamin 
C for irradiated human lymphocytes in vitro. How-
ever, the best radiation protection efficacy was 
observed for the simultaneous ingestion of both 
radioprotective agents. In irradiated samples, a 
statistically significant difference in the total num-
ber of micronuclei was observed between samples 
treated by melatonin or vitamin C and those treat-
ed by the combination of melatonin and vitamin C 
(P<0.05, Fig.2).
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Table 1:  The percentage of micronuclei induced by exposure to 2 Gy of 6 MV-radiation in blood lymphocytes at 10 minutes before, and 
at 1, 2 and 3 hours after administration of melatonin (group A) (P<0.001)
Time          At 0 hour                                At 1 hour                              At 2 hours                          At 3 hours
Volunteer no. Control Irradiated Control Irradiated Control Irradiated Control Irradiated
1 0.6 10.3 0.7 5.3 0.8 8.2 0.6 9.7
2 0.6 11.1 0.8 6.1 0.7 9.4 0.5 11.9
3 0.5 12.2 0.6 7.3 0.4 10.3 0.7 11.5
4 0.7 9.2 0.6 5.7 0.8 7.32 0.7 8.7
5 0.4 10.7 0.6 4.8 0.2 8.1 0.5 9.6
Table 2:  The percentage of micronuclei induced by exposure to 2 Gy of 6 MV-radiation in blood lymphocytes at 10 minutes before and  
at 1, 2 and 3 hours after administration of vitamin C (group B) (P<0.001)
Time          At 0 hour                                At 1 hour                              At 2 hours                          At 3 hours
Volunteer no. Control Irradiated Control Irradiated Control Irradiated Control Irradiated
1 0.5 10.4 0.6 6.6 0.4 9.6 0.7 10.1
2 0.8 13.1 0.7 9.17 0.6 12 0.7 12.4
3 0.6 11.2 0.5 6.9 0.7 9.5 0.8 10.9
4 0.4 10.8 0.5 7.2 0.7 9.8 0.6 11.8
5 0.7 9.7 0.9 5.8 0.8 8.4 1.1 8.8
Table 3:  The percentage of micronuclei induced by exposure to 2 Gy of 6 MV-radiation in blood lymphocytes at 10 minutes before and 
at 1, 2 and 3 hours after administration of melatonin and vitamin C (group C) (P<0.005)
Time          At 0 hour                              At 1 hour        At 2 hours                     At 3 hours
Volunteer no. Control Irradiated Control Irradiated Control Irradiated Control Irradiated
1 0.5 9.5 0.7 4.1 0.8 6.6 0.9 7.6
2 0.8 11.2 0.7 4.7 0.7 7.9 0.6 9.1
3 0.9 11.8 0.7 5.1 0.8 8.7 0.4 9.7
4 0.8 12.2 0.6 5.2 0.8 8.8 0.7 10.2
5 0.7 10.5 1.1 4.2 0.8 7.5 0.9 8.9
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Fig.1: A typical binucleated lymphocyte with micronuclei.
Fig.2: The average percentages ± SD of micronuclei of lymphocyte 
blood samples exposed to 2 Gy of 6 Mv-radiation before (0 hour) 
and after (1, 2, 3 hours) administration of  radioprotectors, me-
latonin and vitamin C, seperately and combined. MN; Micronucli.
Discussion
A radioprotector with  high efficacy can be used 
to protect people from unwanted exposure in oc-
cupational settings, nuclear accidents, radiothera-
pyand potentially space travel (17, 18).
Two-thirds of chromosomal damages induced 
by ionizing radiation are caused by generated free 
radicals. Antioxidants, due to their ability to scav-
enge the free radicals, can reduce the unfavorable 
effects of ionizing radiation on living systems such 
as chromosomal damages. The ability to scavenge 
free radicals have been demonstrated in many 
studies for melatonin and vitamin C (5, 19-24).
The radiation protection efficacy of vitamin C 
and melatonin was investigated and confirmed, 
both of which are natural compounds in the hu-
man body (24-26). But few human studies have 
been carried out on these agents simultaneously. In 
this study, the ability of x-ray radiation to increase 
the incidence of micronuclei in human lympho-
cytes was confirmed as previously reported (6-8). 
Follow-up of all volunteers for two months after 
participating in this study did not show any side 
effects for melatonin and vitamin C ingestionin all 
three groups. In addition, chromosomal abnormal-
ities were reduced significantly after the adminis-
tration of melatonin, vitamin C and their combi-
nation. Moreover, our results show that combined 
use of melatonin and vitamin C can have a syner-
gistic effect of these compounds. In human stud-
ies (in vitro), significant decrease in chromosomal 
damages caused by gamma radiation in the pres-
ence of these compounds was shown similarly (4, 
5, 17, 18).
We used 200 cGy of 6 MV irradiation since it is 
a standard fraction that is administered to patients 
daily in a fractionation regimen and the highest 
sensitivity for human DNA is obtained for this 
dose of radiation (17). The results of this study 
showed that the maximum  radioprotective effect 
on blood lymphocytes (in all three groups) was ob-
tained 1 hour after melatonin, vitamin C and their 
simultaneous ingestion and this effect was reduced 
over time. 
Conclusion
We conclude that melatonin and vitamin C can 
reduce DNA damage caused by x-ray photons in 
human peripheral blood lymphocytes, if given be-
fore irradiation. Melatonin and vitamin C are natu-
ral compounds in the human body and therefore 
do not have considerable side effects with usual 
administration doses. This study contributes to the 
growing body of evidence on radiation protection 
efficacy of melatonin and vitamin C and reports 
that their combination shows a synergistic effect.
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Due to significant differences between in vitro 
and in vivo conditions for radiation exposure, ad-
ministering melatonin and vitamin C as radiopro-
tectors for clinical applications requires further 
experimental studies by using different cytoge-
netic assays. Moreover, conjugation of these com-
pounds with a monoclonal antibody could increase 
the efficacy of these radioprotective compounds 
for cancer treatment.
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